Biotech News

iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call

iSpecimen (ISPC)iSpecimen2024-03-12 18:07 ESTEarnings

The Company will now report results after the market closes on March 13, 2024 and reschedules conference call to Thursday, March 14, 2024 at 8:30am Eastern

LEXINGTON, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- <a...

Related news

ISPCiSpecimen2023-02-28 16:02 EST

iSpecimen to Report Fourth Quarter and Full Year 2022 Results on March 14, 2023

ISPCiSpecimen2024-03-05 16:30 EST

iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024

View all latest news

iSpecimen

iSpecimen is a healthcare data and biospecimen marketplace company that connects researchers with human biospecimens and related services. Its role is to support research and translational work rather than develop therapies.

Recent company news

ISPCiSpecimen2025-01-16 16:01 EST

iSpecimen Secures Suppliers for COVID-style hMPV Outbreak

ISPCiSpecimen2024-12-20 08:30 EST

iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens

ISPCiSpecimen2024-12-13 07:30 EST

iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers

ISPCiSpecimen2024-12-12 17:11 EST

iSpecimen Appoints Robert Lim as CEO and Director

ISPCiSpecimen2024-11-08 07:30 EST

iSpecimen Named Top Competitor in $4.4 Billion USD Market

Stock data

Close: 1.69 USD
Market cap: 4.41M USD
Exchange: NASDAQ
Sector: Biopharma
Location: United States